YAMANOUCHI VENTURE CAPITAL LLC 4
4 · MEMORY PHARMACEUTICALS CORP · Filed Apr 12, 2004
Insider Transaction Report
Form 4
Transactions
- Conversion
Series D Convertible Preferred Shares
2004-04-08−1,395,349→ 0 total(indirect: See Footnote)→ Common Stock (465,116 underlying) - Conversion
Common Stock
2004-04-08+465,116→ 465,116 total(indirect: See Footnote)
Footnotes (4)
- [F1]The shares of Series D Convertible Preferred Stock reported consist of shares held of record by each of the entities listed below. Yamanouchi Venture Capital, LLC is 100% owned by Yamanouchi Group Holding, Inc., which is in turn owned by Yamanouchi Pharmaceutical Co., Ltd. Each of the Filing Persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein.
- [F2]Each share of Convertible Preferred Stock converted into .3333 shares of Common Stock.
- [F3]These securities automatically converted into Common Stock upon the closing of the issuer?s initial public offering.
- [F4]These securities do not have an expiration date.